Efficacy and safety of Le Fort colpocleisis in the treatment of stage III-IV pelvic organ prolapse

BMC Women's Health

Table 4 Results of questionnaires at preoperative and last follow-up time

Questionnaire	Scale	Score	Status	Median	Interquartile range	Range	Improvement ≥ 70%, n, (%)
PFDI-20	POPDI-6	0–100	Pre-	37.5	33.25–41.75	21–62.5	54(100)
	POPDI-6	0–100	Last-	0	0–0	0–0	54(100)
	CRADI-8	0–100	Pre-	0	0–0	0–18.75	3(5.56)
	CRADI-8	0–100	Last-	0	0–0	0–18.75	3(5.56)
	UDI-6	0–100	Pre-	2.13	0–29.25	0–58.25	20(37.04)
	UDI-6	0–100	Last-	0	0–8.25	0–33.25	20(37.04)
	Total	0–300	Pre-	45.31	37.5–69.75	21–113.38	47(87.04)
	Total	0–300	Last-	0	0–8.25	0–33.25	47(87.04)
PFIQ-7	POPIQ-7	0–100	Pre-	57.14	52.38–76.19	33.33–90.48	53(98.15)
	POPIQ-7	0–100	Last-	0	0–0	0–47.62	53(98.15)
	CRAIQ-7	0–100	Pre-	0	0–0	0–28.57	4(7.41)
	CRAIQ-7	0–100	Last-	0	0–0	0–23.81	4(7.41)
	UIQ-7	0–100	Pre-	0	0–38.1	0–85.71	19(35.19)
	UIQ-7	0–100	Last-	0	0–3.57	0–38.1	19(35.19)
	Total	0–300	Pre-	78.57	57.14–108.32	33.33–176.19	46(85.19)
	Total	0–300	Last-	0	0–14.29	0–47.62	46(85.19)

ISSN: 1472-6874